Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05241405 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer

Study acronym: QISEIN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 10 sites
    • Eligibility criteria expanded, about 1 word
    v6
  2. Primary and study completion dates: Sep 2025 to Sep 2027
    • Eligibility criteria expanded, about 18 words
    • Study title expanded, about 2 words
    v5
  3. Site details revised at 2 of 10 sitesv4
  4. Study sites: 9 to 10
    • Eligibility criteria expanded, about 8 words
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2022 to Sep 27, 2022
    • Study sites: 1 to 9
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American ginseng combined with vitamin C from extract of Camu Camu berries
Trial Details
NCT Number NCT05241405
Lead Sponsor Centre Francois Baclesse
Collaborators: NATSUCA laboratory, Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions
(from sponsor)		 Breast Cancer, Fatigue
Related terms Breast Neoplasms, Fatigue
Enrollment 354 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov